Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

344
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
344
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

310
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
310
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

305
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
305
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

8.8K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
8.8K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

310
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
310
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

324
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
324

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hashimoto's Thyroiditis Beyond Thyroid Hormones: A Systematic Review of Autoimmunity, Inflammation, and Multidimensional Burden.

Clinical endocrinology·2026
Same author

Pharmacological interactions between psychotropic drugs and anticancer treatments: implications for clinical practice.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Host Immunogenetics and Chronic HCV Infection Shape Atopic Risk in Pediatric Beta-Thalassemia: A Genotype-Phenotype Study.

Genes·2025
Same author

Eosinophil ETosis and Cancer: Ultrastructural Evidence and Oncological Implications.

Cancers·2025
Same author

The Emerging Role of N-Acetylcysteine in Psychiatry: A Narrative Review of Available Data.

Current medicinal chemistry·2025
Same author

Interoceptive sensibility mediates emotional dysregulation: Insights from individuals with Bipolar II Depression.

Journal of affective disorders·2025

Related Experiment Video

Updated: Mar 20, 2026

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
05:41

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

Published on: February 9, 2024

1.2K

The thyroid disease in the elderly: Our experience.

Matteo Angelo Cannizzaro1, Antonino Buffone1, Salvatore Lo Bianco1

  • 1Department of Medical and Surgical Sciences, Advanced Technologies " G.F.Ingrassia", University of Catania, Italy.

International Journal of Surgery (London, England)
|June 4, 2016
PubMed
Summary

Elderly individuals often exhibit atypical thyroid disease symptoms, leading to delayed diagnosis. This study highlights reduced thyroid hormone secretion and metabolism in older adults, impacting disease presentation.

Keywords:
AgeingElderlyHyperthyroidismHypothyroidismThyroid

More Related Videos

Author Spotlight: Accurately Assessing Thyroid Hormone-Driven Motor Alterations in Mouse
04:05

Author Spotlight: Accurately Assessing Thyroid Hormone-Driven Motor Alterations in Mouse

Published on: October 6, 2023

824

Related Experiment Videos

Last Updated: Mar 20, 2026

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
05:41

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

Published on: February 9, 2024

1.2K
Author Spotlight: Accurately Assessing Thyroid Hormone-Driven Motor Alterations in Mouse
04:05

Author Spotlight: Accurately Assessing Thyroid Hormone-Driven Motor Alterations in Mouse

Published on: October 6, 2023

824

Area of Science:

  • Geriatric Medicine
  • Endocrinology
  • Thyroidology

Background:

  • The Italian population is aging, necessitating research into age-related disease presentations.
  • Thyroid disorders are common, and their manifestation can differ significantly in elderly patients.

Purpose of the Study:

  • To investigate the differences in thyroid disease incidence and presentation between elderly (≥65 years) and younger (<65 years) patient groups.
  • To analyze the specific challenges in diagnosing thyroid conditions in the aging population.

Main Methods:

  • Retrospective analysis of 1362 patients who underwent thyroidectomy between January 2008 and December 2014.
  • Patients were categorized into two age groups: Group A (≥65 years) and Group B (<65 years).

Main Results:

  • Elderly patients frequently present with nonspecific symptoms mimicking the aging process.
  • Hypothyroidism in the elderly often occurs sub-clinically, while hyperthyroidism may manifest with cardiovascular symptoms.
  • Reduced secretion and metabolization of thyroid hormones were observed in the elderly group.

Conclusions:

  • Thyroid diseases in the elderly often present atypically, potentially delaying diagnosis.
  • Age-related changes in thyroid hormone metabolism contribute to nonspecific symptomatology.
  • Understanding these differences is crucial for timely and accurate diagnosis in geriatric patients.